Off-Label Gabapentin Use Up Despite ‘Dearth of Evidence’
The use of gabapentinoids by adults in the United States has increased to 4.7% in 2021 from 4% in 2015, with many of the drugs being prescribed off label for chronic pain conditions despite minimal evidence supporting their use. The study, which analyzed data from the 2002-2021 Medical Expenditure Panel Survey, found that use of…